J&J Testing Division Sells for $4.15B

Jan 16, 2014

Market Watch

The Carlyle Group private equity firm has agreed to acquire the clinical testing division of Johnson & Johnson for $4.15 billion.

The deal for the Ortho-Clinical Diagnostics unit, a NJ-based healthcare screening, diagnosis and monitoring solutions provider, it is expected to close in the middle of this year.

Read the Market Watch press release

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.


No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments